Video
Transperineal biopsy device PrecisionPoint shows promise
Author(s):
“Through these 2 small punctures, we can manipulate the device with the methodology to sample the entire prostate, both anterior apical and the posterior regions, where we find the vast majority of our cancers,” says Matthew A. Allaway, MD.
Video Player is loading.
This is a modal window.
The Playback API request failed for an unknown reason
Error Code: VIDEO_CLOUD_ERR_UNKNOWN
Technical details
:
Session ID: 2025-05-19:47d95f77f0e751d7992bf7d Player Element ID: vjs_video_896
In this video, Matthew J. Allaway, MD, discusses the The PrecisionPoint Transperineal Access System, a new and efficient methodology for detecting prostate cancers in patients. Allaway is the founder and president of Perinealogic, urologist and managing partner at Urology Associates, Cumberland, Maryland.
Related Videos
Laura Davis, MD, on link between microplastics and bladder cancer
Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
Considerations for patient follow-up after onabotA administration
Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
Administering onabotA: Improving patient comfort and easing anxiety
Expert discusses genitourinary syndrome of menopause guidelines
Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone prevention
Comparing Trials Studying Treatment Intensification In mHSPC
An Overview of the ARANOTE Trial
Related Content
